Evaluation of the health economic impact of initial diagnostic modality selection in patients suspected of having HCC in China and the USA
Author:
Affiliation:
1. Bayer AG, Berlin, Germany
2. Department of Pharmaceuticals, Bayer Healthcare Company Limited, Beijing, China
3. Wickenstones Ltd., Carlow, Ireland
Funder
Bayer
Publisher
Informa UK Limited
Subject
Health Policy
Link
https://www.tandfonline.com/doi/pdf/10.1080/13696998.2022.2110353
Reference24 articles.
1. Hepatocellular Carcinoma
2. Society AC. 2021 [cited 2021 Jun 11]. Available from: https://www.cancer.org/cancer/liver-cancer/detection-diagnosis-staging/survival-rates.html
3. How grim is hepatocellular carcinoma?
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The lncRNA lnc-TSI antagonizes sorafenib resistance in hepatocellular carcinoma via downregulating miR-4726-5p expression and upregulating KCNMA1 expression;Journal of Molecular Histology;2024-01-02
2. Analysis of the safety and effectiveness of TACE combined with targeted immunotherapy in the treatment of intermediate and advanced hepatocellular carcinoma;Medical Oncology;2023-07-27
3. Evaluation of health economic impact of initial diagnostic modality selection for colorectal cancer liver metastases in suspected patients in China, Japan and the USA;Journal of Medical Economics;2023-02-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3